Medication dosing and renal insufficiency in a pediatric cardiac intensive care unit: Impact of pharmacist consultation

Pediatric Cardiology

Volumn 29, Issue 4, 2008, Pages 744-748

  Moffett, Brady S ^a   Mott, Antonio R ^b   Nelson, David P ^b   Gurwitch, Karen D ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiac surgery; Intensive care; Medication adjustment; Pediatric; Pharmacist interventions; Renal insufficiency

Indexed keywords

AMPICILLIN; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTIHYPERTENSIVE AGENT; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUCONAZOLE; GANCICLOVIR; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; PROKINETIC AGENT; RANITIDINE; URICOSURIC AGENT;

AGE DISTRIBUTION; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CONSULTATION; CONTROLLED STUDY; COST CONTROL; CREATININE BLOOD LEVEL; DEMOGRAPHY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; ECONOMIC ASPECT; HEART DISEASE; HEART SURGERY; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; NEWBORN; PERITONEAL DIALYSIS; PHARMACIST; PRACTICE GUIDELINE; PRESCRIPTION; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; CARDIAC SURGICAL PROCEDURES; CHILD, PRESCHOOL; CORONARY CARE UNITS; DRUG DOSAGE CALCULATIONS; HEART DISEASES; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; PHARMACY; REFERRAL AND CONSULTATION; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 46749085207     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-007-9170-3     Document Type: Article

References (26)

1. Ariano RE, Demianczuk RH, Danziger RG, Richard A, Milan H, Jamieson B (1995) Economic impact and clinical benefits of pharmacist involvement on surgical wards. Can J Hosp Pharm 48(5):284-289
2. Asfour B, Bruker B, Kehl HG, Frund S, Scheld HH (1996) Renal insufficiency in neonates after cardiac surgery. Clin Nephrol 46(1):59-63
3. Baskin E, Saygili A, Harmanci K, et al. (2005) Acute renal failure and mortality after open-heart surgery in infants. Renal Fail 27(5):557-560
4. Buck ML (2003) Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates. Clin Pharmacokinet 42(5):403-417
5. Chan K, Ip P, Chiu CSW, Cheung Y (2003) Peritoneal dialysis after surgery for congenital heart disease in infants and young children. Ann Thorac Surg 76:1443-1449
6. Chertow GM, Lee J, Kuperman GJ, et al. (2001) Guided medication dosing for patients with renal insufficiency. JAMA 286:2839-2844
7. Chesney RW, Kaplan BS, Freedom RM, Haller JA, Drummond KN (1975) Acute renal failure: an important complication of cardiac surgery in infants. J Pediatr 87(3):381-388
8. Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
9. Daschner M (2005) Drug dosage in children with reduced renal function. Pediatr Nephrol 20(12):1675-1686
10. Dittrich S, Kurschat K, Dahnert I, et al. (2000) Renal function after cardiopulmonary bypass surgery in cyanotic congenital heart disease. Int J Cardiol 73:173-179
11. Elwell RJ, Bailie GR, Manley HJ (2000) Correlation of intraperitoneal antibiotic pharmacokinetics and peritoneal membrane transport characteristics. Perit Dial Int 20(6):694-698
12. Falconnier AD, Haefell WE, Schoenenberger RA, Surber C, Martin-Facklam M (2001) Drug dosage in patients with renal failure optimized by immediate concurrent feedback. J Gen Intern Med 16:369-375
13. Filler G, Lepage N (2003) Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 18(10):981-985
14. Folli HL, Poole RL, Benitz WE, Russo JC (1987) Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics 79(5):718-722
15. Golightly LK, O'Fallon CL, Moran WD, Sorocki AH (1993) Pharmacist monitoring of drug therapy in patients with abnormal serum creatinine levels. Hosp Pharm 28(8):725-7-730-2
16. Harrison AM, Davis S, Eggleston S, Cunningham R, Mee RB, Bokesch PM (2003) Serum creatinine and estimated creatinine clearance do not predict perioperatively measured creatinine clearance in neonates undergoing congenital heart surgery. Pediatr Crit Care Med 4(1):55-59
17. Keller E (1988) Peritoneal kinetics of different drugs. Clin Nephrol 30(Suppl 1):S24-S28
18. Krupicka MI, Bratton SL, Sonnenthal K, Goldstein B (2002) Impact of a pediatric clinical pharmacist in the pediatric intensive care unit. Crit Care Med 30(4):919-921
19. Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettila V (2006) Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg 81(2):542-546
20. Nash IS, Rojas M, Hebert P, et al. (2005) Reducing excessive medication administration in hospitalized adults with renal dysfunction. Am J Med Qual 20:64-69
21. Paton TW, Cornish WR, Manuel MA, Hardy BG (1985) Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations. Clin Pharmacokinet 10(5):404-425
22. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58(2):259-263
23. Taketomo CK, Hodding JH, Kraus DM (2006) Pediatric Dosage Handbook, 13th ed. Lexi-Comp, Inc., Hudson, OH
24. Wade EE, Rebuck JA, Healey MA, Rogers FB (2002) H(2) antagonist-induced thrombocytopenia: is this a real phenomenon? Intensive Care Med 28(4):459-465
25. Wang JK, Herzog NS, Kaushal R, Park C, Mochizuki C, Weingarten SR (2007) Prevention of pediatric medication errors by hospital pharmacists and the potential benefit of computerized physician order entry. Pediatrics 119(1):e77-e85
26. Wijeysundera DN, Karkouti K, Beattie S, Rao V, Ivanov J (2006) Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology 104:65-72